Thermo Fisher Scientific Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TMO research report →
Range $490 – $683
Price Chart
About the company
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets.
- CEO
- Marc N. Casper
- IPO
- 1980
- Employees
- 125,000
- HQ
- Waltham, MA, US
Get TickerSpark's AI analysis on TMO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $193.95B
- P/E
- 28.65
- Fwd P/E
- 21.00
- PEG
- 4.37
- P/S
- 4.29
- P/B
- 3.74
- EV/EBITDA
- 20.95
- Div Yield
- 0.34%
- Gross Margin
- 39.41%
- Op Margin
- 17.76%
- Net Margin
- 15.18%
- ROE
- 13.26%
- ROIC
- 7.33%
Latest fiscal year · YoY change
- Revenue
- $44.56B+3.9%
- Gross Profit
- $16.78B-5.4%
- Op Income
- $8.11B
- Net Income
- $6.74B+6.3%
- EPS
- $17.77+7.2%
- OCF Growth
- -9.8%
- FCF Growth
- -13.4%
- 52W High
- $643.99
- 52W Low
- $435.27
- 50D MA
- $486.19
- 200D MA
- $529.43
- Beta
- 0.87
- RSI (14)
- 56
- Avg Volume
- 2.36M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the TMO Q1 '26 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 99.7%
- Shares Outstanding
- 371.62M
- Float Shares
- 370.67M
of shares held by institutions
2,655 13F filers
Buy/sell ratio 5.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for TMO, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Dan NewhouseHouse · WA04 | Sell | Jul 10, 26 | Filing → |
| Dwight EvansHouse · PA03 | Sell | May 7, 26 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Apr 13, 26 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Mar 6, 26 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 29, 26 | Filing → |
| Julia LetlowHouse · LA05 | Sell | Apr 28, 25 | Filing → |
| Julia LetlowHouse · LA05 | Buy | Oct 23, 24 | Filing → |
| Julia LetlowHouse · LA05 | Buy | Jul 25, 25 | Filing → |
| Valerie HoyleHouse · OR04 | Sell | Sep 23, 25 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Sep 29, 25 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Sep 12, 25 | Filing → |
| Kelly Louise MorrisonHouse · MN03 | Sell | Aug 19, 25 | Filing → |
| Valerie HoyleHouse · OR04 | Sell | Mar 3, 25 | Filing → |
| Valerie HoyleHouse · OR04 | Buy | Jun 6, 25 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 34.13M | ▲ 288.30K |
| Blackrock, Inc. | 30.43M | ▼ 250.69K |
| State Street Corp | 16.73M | ▲ 117.91K |
| Morgan Stanley | 10.86M | ▼ 1.03M |
| Fmr LLC | 10.78M | ▲ 983.09K |
| Geode Capital Management, LLC | 8.41M | ▲ 211.41K |
| Franklin Resources Inc | 6.81M | ▲ 466.52K |
| Jpmorgan Chase & Co | 6.80M | ▲ 183.60K |
| Capital World Investors | 6.65M | ▼ 4.36M |
| Price T Rowe Associates Inc | 6.32M | ▼ 1.39M |
| Bank Of America Corp | 5.53M | ▼ 412.44K |
| Norges Bank | 5.30M | ▲ 5.30M |
Held by 1,837 ETFs
Biggest fund positions in TMO by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 27, 26 | SPERLING SCOTT M | other | 82.84 |
| Jun 27, 26 | Keith R. Alexandra | other | 60.91 |
| Jun 27, 26 | WEISLER DION J | other | 73.1 |
| Jun 27, 26 | Lynch Karen S | other | 60.91 |
| Jun 27, 26 | JOHNSON JENNIFER M | other | 60.91 |
| May 20, 26 | WEISLER DION J | other | 499 |
| May 20, 26 | WEISLER DION J | other | 80.287 |
| May 20, 26 | SPERLING SCOTT M | other | 499 |
| May 20, 26 | Spar Debora L | other | 499 |
| May 20, 26 | Lynch Karen S | other | 499 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our TMO coverage
Recent articles, reports, and earnings notes.
Thermo Fisher Scientific (TMO): Quality Franchise, Price Debate
Thermo Fisher Scientific remains a top-tier life sciences platform with recurring revenue, strong cash flow, and multiple growth catalysts. The stock is a Buy, but the report argues the main question is valuation rather than business quality.
The Best Healthcare Stocks Right Now (Updated June 2026)
These seven healthcare stocks combine recurring demand, identifiable franchises, and varying mixes of scale, profitability, and growth heading into June 2026.
Thermo Fisher Scientific Inc. (TMO) drops 9.2% on earnings
Thermo Fisher Scientific Inc. (TMO) drops after reporting a Q1 2026 earnings beat on revenue and EPS. Investors are focusing instead on margin pressure, mixed segment performance, and whether guidance can justify the stock’s premium valuation.
Want a deeper read on TMO?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Acumen Wealth Advisors LLC Sells 2,166 Shares of Thermo Fisher Scientific Inc. $TMO
defenseworld.net · Jul 22
ImmuPharma picks Thermo Fisher to manufacture diabetes drug candidate
proactiveinvestors.co.uk · Jul 22
Andra AP fonden Purchases 53,990 Shares of Thermo Fisher Scientific Inc. $TMO
defenseworld.net · Jul 21
Exploring Analyst Estimates for Thermo Fisher (TMO) Q2 Earnings, Beyond Revenue and EPS
zacks.com · Jul 20
AIA Group Ltd Cuts Stock Holdings in Thermo Fisher Scientific Inc. $TMO
defenseworld.net · Jul 19
Thermo Fisher Set to Report Q2 Earnings: What's in the Cards?
zacks.com · Jul 15
TMO Fairly Valued by DCF at $478
gurufocus.com · Jul 13
Thermo Fisher Scientific Announces Quarterly Dividend
businesswire.com · Jul 9
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
Bullish or bearish?
Where do you stand on TMO?